OYC News & Press Releases
Featured Product: ALP Conjugate Blocking Agent
May 3, 2012
OYC Americas offers a unique enzyme that inhibits non-specific binding of ALP conjugates, Scavanger Alkaline Phosphatase (S-ALP).  Our enzyme eliminates interference of substances associated with ALP based high sensitive immunoassays; including autoantibodies from calf intestine and matrix effect interference from human clinical samples. See Enzymes, sALP
 
Open House Ceremony in Vista, CA
March 7, 2012

Thanks to the Vista Chamber and the Carlsbad Chamber for welcoming
OYC Americas to Southern CA!

 
OYC Americas Opens New Customer Operations Center
February 3, 2012
17 January 2012

For Immediate Release

Yeast Technology Company Grows Into Vista

VISTA, CA: In a move that brings a vital resource closer to the San Diego biotechnology community, OYC Americas has expanded from their east coast office into a new Customer Operations Center in Vista, California.

A wholly-owned subsidiary of Oriental Yeast Company headquartered in Japan, OYC Americas provides raw materials derived from yeast fermentation technology for clinical diagnostics, pharmaceutical, nutraceutical, and the food and functional food industries. Used in products ranging from diagnostics and gene research to biofuels research and manufacturing, yeast technology plays an essential role in today’s medical and biotech fields – a role that’s growing as the demand for fermentation increases.

Ted Kottcamp, President of OYC Americas, says this new Customer Operations Center is an important advance in their ability to deliver Japanese quality with American responsiveness and flexible customer service.

“Our customers will certainly notice how this expansion improves our ability to serve them,” said Kottcamp, speaking from the new office. “Having our Operations Center here in Vista allows us to streamline supply-chain logistics with our parent company in Japan. And that means we anticipate real improvements to our already high standards of customer service.”

“On top of that,” Kottcamp added, “we have enhanced warehousing facilities here, with both room-temperature and refrigerated storage – so we can be even more responsive to our customers’ needs since we have the local warehousing capacity to meet anticipated demand.”

This expansion aligns OYC Americas with global expansion plans announced on New Year’s Day by their Japanese parent. And it brings a rich source of biotechnology materials – or more specifically, yeast technology materials – to Southern California.

“Of course we’re looking forward to being a vital part of the San Diego biotech community,” said Kottcamp. “More importantly, though, we’re looking forward to being a part of the San Diego business community as a whole. This area has so much to offer, and we’re delighted to be here and to be able to contribute!”

ABOUT OYC AMERICAS: OYC Americas is a sales and marketing company committed to supporting human healthcare innovations within the Clinical Diagnostic, Pharmaceutical, Nutraceutical, Food, and Functional Food industries. Our goal is to provide value to Research & Development, Manufacturing, and Marketing by supplying unique raw materials, food ingredients and ingredient technologies developed by our parent company, Oriental Yeast, Co., Ltd of Japan and associated partnerships. We strive to meet the regulatory demands of the human health and nutrition industry with products developed through scientific research and clinical support. Our business partnerships are earned and maintained with a long-term commitment to quality, service, and dedication to the science of human health.

 
Recombinant human Laminin 5 as a potent extracellular matrix protein to enhance cell adhesion
December 7, 2010
Recombinant human Laminin-5 from Oriental Yeast Co., Ltd. illustrated superior performance against other extracellular matrix proteins in a feeder-free culture system of human iPS cells; reported in the 9th Congress of the Japanese Society for Regenerative Medicine (March 18, 2010).
 
Anti-murine RANKL antibody used for in-vivo research by The Walter and Eliza Hall Institute of Medical Research, Australia

April 13, 2010 - Toyko, Japan - Oriental Yeast Company, OYC Americas' parent company, is pleased to announce its anti-murine RANKL monoclonal antibody was used in the study "Control of mammary stem cell function by hormone signaling" that was published by Nature, the international weekly journal of science.

Read more...
 
OYC Americas successfully launched the Advanced Medical Labs brand of nutritional supplements

November 2009 - Las Vegas, Nev. and Nashua, N.H. - OYC Americas, Inc. successfully launched the Advanced Medical Labs brand of nutritional supplements at the ACAM conference in Las Vegas and the NHAND conference in Nashua, NH. A new line of herbal and botanical products from NaturaTM Apothecary was also introduced at the NHAND conference and are specifically designed to meet the needs of the naturopathic physician.

Read more...
 
New partnerships launch OYC Americas’ entrance into health supplement market
November 3, 2009

Andover, Mass. - After more than 15 years of building a reputation of supplying high-quality raw materials in the life science industry, OYC Americas announced today that it has partnered with two reputable makers of health supplements to expand its offerings.

Read more...
 
OYC offers Recombinant Enzymes for Clinical Chemistry
August 29, 2009
OYC Americas is pleased to offer our Recombinant Enzymes for Clinical Chemistry.
Read more...
 
<< Start < Prev 1 2 Next > End >>

Page 1 of 2
Upcoming Events